GlassScriptPhysician profile
Elizabeth A Baehler
NPI 1417979410
$892.65
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $92.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $167.99 | 2019 | |
| Amgen INC. | $85.04 | 2019-2020 | |
| Celgene Corporation | $83.28 | 2019-2020 | |
| Incyte Corporation | $68.86 | 2019-2020 | |
| Janssen Biotech, INC. | $65.39 | 2019 | |
| Rigel Pharmaceuticals, INC. | $56.31 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.32 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $39.04 | 2019 | |
| Lilly USA, LLC | $34.07 | 2019 | |
| Merck Sharp & Dohme LLC | $31.66 | 2019 | |
| Daiichi Sankyo INC. | $30.07 | 2019 | |
| Kyowa Kirin, INC. | $28.13 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.55 | 2019 | |
| Genzyme Corporation | $19.59 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $16.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $15.28 | 2020 | |
| Seagen INC. | $14.95 | 2020 | |
| Taiho Oncology, INC. | $14.40 | 2019 | |
| Advanced Accelerator Applications | $14.32 | 2019 | |
| Agios Pharmaceuticals, INC. | $14.08 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.87 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Baehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.